7 recruiting. 7 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Recruiting 7 |
| Phase 1 | 2 | Recruiting 2 |
| Phase 3 | 1 | Recruiting 1 |
Follow Aneurysm: new trials by email Literature Review of Aneurysm trials Research Report on Aneurysm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HEART: Pilot Randomized Controlled Trial Spironolactone, Placebo - Thoracic Aortic Aneurysm | Phase 1 / Phase 2 | Recruiting | Mayo Clinic | 50 | 2026-05-25 | 2026-06-08 |
| Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms Infliximab - Aneurysm, Stroke | Phase 1 / Phase 2 | Recruiting | University of California, San Francisco | 8 | 2024-10-01 | 2026-06-11 |
| Vasodilator and Exercise Study for DMD (VASO-REx) Tadalafil, Placebo, Exercise Training - Duchenne Muscular Dystrophy, Duchenne Disease | Phase 2 | Recruiting | University of Florida | 50 | 2024-06-05 | 2026-05-15 |
| Nectero EAST System Clinical Study Nectero EAST System - Abdominal Aortic Aneurysm | Phase 2 / Phase 3 | Recruiting | Nectero Medical, Inc. | 400 | 2023-10-25 | 2026-09-28 |
| Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome tocilizumab, tofacitinib, cyclophosphamide - Aneurysm, Behcet Syndrome, Vascular Type | Phase 2 | Recruiting | Peking Union Medical College Hospital | 81 | 2023-06-01 | 2024-08-19 |
| Ischemic Conditioning to Promote Microvascular Resiliency in Frail Individuals Ischemic Conditioning - Aging, Fragility | Phase 2 | Recruiting | Medical College of Wisconsin | 60 | 2023-05-02 | 2025-09-23 |
| Limiting AAA With Metformin (LIMIT) Trial Metformin, Placebo - Abdominal Aortic Aneurysm | Phase 2 | Recruiting | Stanford University | 314 | 2022-02-28 | 2025-04-18 |
Aortic Aneurysm, Abdominal (2) · Motor Activity (2) · Aortic Aneurysm (1) · Aortic Aneurysm, Thoracic (1) · Behcet Syndrome (1) · Muscular Dystrophies (1) · Muscular Dystrophy, Duchenne (1) · Stroke (1) · Tabes Dorsalis (1) · Vasculitis (1)
Cardiovascular Diseases (7) · Vascular Diseases (7) · Aortic Diseases (3) · Aortic Aneurysm (2) · Behavior (2) · Central Nervous System Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Nervous System Diseases (2) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Brain Diseases (1) · Central Nervous System Bacterial Infections (1) · Central Nervous System Infections (1)
Cyclophosphamide (1) · Exercise (1) · Infliximab (1) · Metformin (1) · Spironolactone (1) · Tadalafil (1) · tocilizumab (1) · tofacitinib (1)
Mayo Clinic (1) · Medical College of Wisconsin (1) · Nectero Medical, Inc. (1) · Peking Union Medical College Hospital (1) · Stanford University (1) · University of California, San Francisco (1) · University of Florida (1)
United States (6) · Australia (1) · China (1) · New Zealand (1)
Daniel Clair, MD (1) · Daniel L Cooke, MD (1) · Grace Wang, MD (1) · Ronald Dalman, MD (1) · Tanja Taivassalo, Ph.D. (1) · Thais Coutinho (1)
R21AR079755 (1), R33HL146835 (1), R61HL146835 (1)